Executive Vice President, Global Rare Diseases (Board member), Chiesi Farmaceutici Spa Chiesi
Verified interview transcripts, podcast appearances, and direct quotes from Giacomo Chiesi, Executive Vice President, Global Rare Diseases (Board member) at Chiesi Farmaceutici Spa Chiesi. AI-verified speaker identity with full-text searchable transcripts.
“We do science for the sake of patients and not science for the sake of science and we love to take in treatments all the way to the patient homes.”
“With only five percent of rare diseases that have an approved or experimental therapy, there's a huge work to do ahead of us.”
“We do not just pursue growth for the sake of growth, we want to pursue sustainable and sustained growth. Sustainable for us means that we just don't care only about maximizing shareholder value, or we don't just care about taking the product to the patients. We care about society at large in nature and the environment.”
“The way we look at risk is you can't run away from risk. You just can't. If your philosophy and your mission is pursue opportunity, then you're pursuing risk. You shouldn't run away from risk. You should attack risk. And when you attack risk, that means you should go in and demolish it by decomposing it into its pieces...”
Quali sono le opportunità e le sfide per un’azienda farmaceutica che opera nel campo delle malattie rare? Lo abbiamo chiesto a Giacomo Chiesi, Head of Global Rare Diseases at the Chiesi Group, che abbiamo incontrato a Milano in occasione di un evento di aggiornamento sulla malattia.
Giacomo Chiesi, of Chiesi Global Rare Diseases, receives the 2021 RARE Champion of Hope Award for Industry from Global ...
Giacomo Chiesi, Head of Global Rare Diseases, describes the driving force behind our mission to let the patient voice shape who we are in recognition of Rare Disease Day 2021.
StartUp Health’s Katya Hancock sat down with Giacomo Chiesi at the 2019 StartUp Health Festival for a one-on-one fireside chat. The pair discussed the values of the family-run, mid-sized pharma company Chiesi Pharmaceuticals and the unique opportunities and advantages for startups in partnering with them -- including the current StartUp Health and Chiesi call for innovations for rare disease. WATCH MORE NOW EPISODES: https://www.startuphealth.com/startup... #Chiesi #ChiesiGroup #ChiesiFarmaceutici #ChiesiVentures #Farmaceutici #GlobalReach #GiacomoChiesi
Sign in to search the full transcript archive, filter by topic, and access every quote from Giacomo Chiesi.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →